Last week we mentioned that one specific form of micro-ribonucleic acid (miRNA) may be usable in the development of a drug or drugs to stop the process of metastasis in men with high-risk forms of prostate cancer. Another recent study goes one step further than that. … READ MORE …
Filed under: Diagnosis, Drugs in development, Management, Risk, Treatment | Tagged: miRNA, prognosis, research, risk, test, Treatment | Leave a comment »
No currently known biomarker can accurately predict the risk of prostate cancer recurrence at the time of or immediately following first-line treatment for localized prostate cancer. The best we can currently manage is to track a patient’s PSA level and his PSA doubling time. … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: miRNA, mitochondrial, prognosis, recurrence, RNA | 3 Comments »
Since (after yesterday’s glut) there appear to be no new news reports for the weekend, we thought it might be useful to offer a little education on so-called “micro RNAs” and their potential roles in prostate cancer. … READ MORE …
Filed under: Diagnosis, Drugs in development, Management, Prevention, Risk, Treatment | Tagged: micro RNA, miRNA | 1 Comment »
THE "NEW" PROSTATE CANCER INFOLINK 